您的位置：山东大学 -> 科技期刊社 -> 《山东大学学报（医学版）》

山东大学学报 (医学版) ›› 2022, Vol. 60 ›› Issue (2): 27-31.doi: 10.6040/j.issn.1671-7554.0.2021.1307

• 临床医学 • 上一篇    下一篇

聚腺苷酸二磷酸核糖聚合酶-1在子宫内膜异位症中的表达及意义

林雪艳1,张灿灿2,田民乐3,田永杰1,4   

  1. 1. 山东第一医科大学附属省立医院妇产科, 山东 济南 250021;2. 山东大学附属山东省妇幼保健院妇科, 山东 济南 250014;3. 山东第一医科大学基础医学院, 山东 济南 250118;4. 山东大学附属省立医院妇产科, 山东 济南 250021
  • 发布日期:2022-01-25
  • 通讯作者: 田永杰. E-mail:tianyongjie@sdu.edu.cn
  • 基金资助:
    山东省自然科学基金(ZR2019MH129);中华预防医学会科研资金支持项目(201815072)

Expression and significance of poly(ADP-ribose) polymerase-1 in endometriosis

LIN Xueyan1, ZHANG Cancan2, TIAN Minle3, TIAN Yongjie1,4   

  1. 1. Department of Obstetrics and Gynecology, Shandong Provincial Hospital Affiliated to Shandong Frist Medical University, Jinan 250021, Shandong, China;
    2. Department of Gynecology, Shandong Provincial Maternal and Child Health Care Hospital, Cheeloo College of Medicine, Shandong University, Jinan 250014, Shandong, China;
    3. School of Basic Medicine, Shandong First Medical University, Jinan 250118, Shandong, China;
    4. Department of Obstetrics and Gynecology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan 250021, Shandong, China
  • Published:2022-01-25

摘要： 目的 检测聚腺苷酸二磷酸核糖聚合酶-1(PARP-1)在子宫内膜异位症患者在位内膜和异位内膜组织中的表达,并探讨PARP-1与E-cadeherin、vimentin和Snail在子宫内膜异位症患者内膜中表达的相关性。 方法 采用免疫组织化学SP法检测PARP-1、E-cadeherin、vimentin和Snail在子宫内膜异位症患者在位内膜、异位内膜、正常子宫在位内膜中的表达。采用Spearman方法分析PARP-1与E-cadeherin、vimentin和Snail之间表达的相关性。 结果 PARP-1、vimentin和Snail在子宫内膜异位症患者在位内膜及异位内膜中的表达比正常子宫在位内膜中的表达增高(P<0.001),E-cadherin在子宫内膜异位症患者在位内膜及异位内膜中的表达较正常子宫在位内膜表达降低(P<0.001)。在子宫内膜异位症患者在位内膜中,PARP-1的表达与E-cadherin呈负相关(r=-0.39),与vimentin和Snail的表达呈正相关(r分别为0.45和0.44);在子宫内膜异位症患者异位内膜中,PARP-1的表达与E-cadherin呈负相关(r=-0.41),与vimentin和Snail的表达呈正相关(r分别为0.48和0.56)。 结论 PARP-1在子宫内膜异位症在位内膜及异位内膜中表达增高,PARP-1可能参与了子宫内膜异位症的上皮间质转化过程。

关键词: 聚腺苷酸二磷酸核糖聚合酶-1, 子宫内膜异位症, 上皮-间质转化, E-cadherin蛋白, Snail蛋白

Abstract: Objective To detect the expression of poly(ADP-ribose)polymerase-1(PARP-1)in eutopic and ectopic endometria of women with endometriosis, and to explore the correlation among PARP-1, E-cadherin, vimentin and Snail in eutopic and ectopic endometria of women with endometriosis. Methods The expressions of PARP-1, E-cadherin, Vimentin and Snail were detected with immunohistochemistry in eutopic and ectopic endometria of women with endometriosis, and in eutopic endometria of women without endometriosis. The correlation among their expressions was determined with Spearman analysis. Results The expressions of PARP-1, vimentin and Snail significantly increased in eutopic and ectopic endometria of women with endometriosis than in endometria of women without endometriosis(P<0.001), while the expression of E-cadherin significantly decreased(P<0.001). In eutopic endometria of endometriosis, the expression of PARP-1 was negatively correlated with E-cadherin(r=-0.39), but positively correlated with the expressions of vimentin and Snail(r=0.45 and 0.44, respectively); in ectopic endometria of endometriosis, the expression of PARP-1 was negatively correlated with E-cadherin(r=-0.41), but positively correlated with the expressions of vimentin and Snail(r=0.48 and 0.56, respectively). Conclusion PARP-1 is highly expressed in eutopic and ectopic endometria of women with endometriosis, PARP-1 may be involved in the epithelial mesenchymal transformation of endometriosis.

Key words: Poly(ADP-ribose)polymerase-1, Endometriosis, Epithelial mesenchymal transformation, E-cadherin protein, Snail protein

中图分类号: 

  • R711.71
[1] Zhu TH, Zhang XM. Research progress on the role of epithelial-mesenchymal transition in pathogenesis of endometriosis [J]. Zhejiang Da Xue Xue Bao Yi Xue Ban, 2016, 45(4): 439-445.
[2] Yang YM, Yang WX. Epithelial-to-mesenchymal transition in the development of endometriosis [J]. Oncotarget, 2017, 8(25): 41679-41689.
[3] Lutz Konrad, Raimund Dietze, Muhammad A Riaz, et al. Epithelial-mesenchymal transition in endometriosis-when does it happen? [J]. Clin Med, 2020, 9(6): 1915. doi: 10.3390/jcm9061915.
[4] Su Shan, Lin XY, Ding N, et al. Effects of PARP-1 inhibitor and ERK inhibitor on epithelial mesenchymal transitions of the ovarian cancer SKOV3 cells [J]. Pharmacol Rep, 2016, 68(6): 1225-1229.
[5] Wei W, Lv SQ, Zhang CC, et al. PARP-1 may be involved in angiogenesis in epithelial ovarian cance r[J]. Oncol Lett, 2016, 12(6): 4561-4567.
[6] Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial-mesenchymal transition [J]. Nat Rev Mol Cell Biol, 2014, 15(3): 178-196.
[7] Biyik I, Kalkan U, Simsek S. The deep infiltrating endometriosis tissue has lower T-cadherin, E-cadherin, progesterone receptor and oestrogen receptor than endometrioma tissue [J]. Taiwan J Obstet Gynecol, 2021, 60(6): 1059-1065.
[8] Batlle E, Sancho E, Francí C, et al.The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells [J]. Nat Cell Biol, 2000, 2(2): 84-89.
[9] Garinet S, Didelot A, Denize T, et al. Clinical assessment of the miR-34, miR-200, ZEB1 and SNAIL EMT regulation hub underlines the differential prognostic value of EMT miRs to drive mesenchymal transition and prognosis in resected NSCLC [J]. Br J Cancer, 2021, 125(11): 1544-1551.
[10] Cano A, Pérez-Moreno MA, Rodrigo I, et al. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression [J]. Nat Cell Biol, 2000, 2(2): 76-83.
[11] Xi L, Yang J, Wang X, et al. Role of TWIST2, E-cadherin and Vimentin in epithelial ovarian carcinogenesis and prognosis and their interaction in cancer progression [J]. Eur J Gynaecol Oncol, 2016, 37(1): 100-108.
[12] Willipinski-Stapelfeldt B, Riethdorf S, Assmann V, et al. Changes in cytoskeletal protein composition indicative of an epithelial-mesenchymal transition in human micrometastatic and primary breast carcinoma cells [J]. Clin Cancer Res, 2005, 11(22): 8006-8014.
[13] Scotti S, Regidor PA, Schindler AE, et al. Reduced proliferation and cell adhesion in endometriosis [J]. Mol Hum Reprod, 2000, 6(7): 610-617.
[14] Zhu H, Wei M, Xu J, et al. PARP inhibitors in pancreatic cancer: molecular mechanisms and clinical applications [J]. Mol Cancer, 2020,19(1): 49. doi: 10.1186/s12943-020-01167-9.
[15] Wei W, Li Y, Lv SQ, et al. PARP-1 may be involved in angiogenesis in epithelial ovarian cancer [J]. Oncol Lett, 2016, 12(6): 4561-4567.
[16] Bahar E, Kim JY, Kim HS, et al. Establishment of Acquired Cisplatin Resistance in Ovarian Cancer Cell Lines Characterized by Enriched Metastatic Properties with Increased Twist Expression [J]. Int J Mol Sci, 2020, 21(20):7613.
[17] Scutiero G, Iannone P, Bernardi G, et al. Oxidative stress and endometriosis: a systematic review of the literature [J]. Oxid Med Cell Longev, 2017, 2017: 7265238.
[18] 郑玉梅, 彭超, 陆叶, 等. 深部浸润型子宫内膜异位症在盆腔子宫内膜异位症中的发生率及其临床病理特征分析[J]. 中华妇产科杂志, 2020, 55(6): 384-389. ZHENG Yumei, PENG Chao, LU Ye, et al. Incidence of deeply infiltrating endometriosis among 240 cases of pelvic endometriosis and analysis of its clinical and pathological characteristics [J]. Chinese Journal of Obstetrics and Gynecology, 2020, 55(6): 384-389.
[19] Béliard A, Donnez J, Nisolle M, et al. Localization of laminin, fibronectin, E-cadherin, and integrins in endometrium and endometriosis [J]. Fertil Steril, 1997, 67(2): 266-272.
[20] Shaco-Levy R, Sharabi S, Benharroch D, et al. Matrix metalloproteinases 2 and 9, E-cadherin, and beta-catenin expression in endometriosis, low-grade endometrial carcinoma and non-neoplastic eutopic endometrium [J]. Eur J Obstet Gynecol Reprod Biol, 2008, 139(2): 226-232.
[21] Pu H, Horbinski C, Hensley PJ, et al. PARP-1 regulates epithelial-mesenchymal transition(EMT)in prostate tumorigenesis [J]. Carcinogenesis, 2014, 35(11): 2592-2601.
[22] Lin Y, Kang T, Zhou BP. Doxorubicin enhances Snail/LSD1-mediated PTEN suppression in a PARP1-dependent manne r[J]. Cell Cycle, 2014, 13(11): 1708-1716.
[23] McPhee TR, McDonald PC, Oloumi A, et al. Integrin-linked kinase regulates E-cadherin expression through PARP-1 [J]. Dev Dyn, 2008, 237(10): 2737-2747.
[24] Chu S, Xu H, Ferro TJ, et al. Poly(ADP-ribose)polymerase-1 regulates vimentin expression in lung cancer cells [J]. Am J Physiol Lung Cell Mol Physiol, 2007, 293(5): L1127-L1134.
[25] Kumar M, Jaiswal RK, Yadava PK, Singh RP. An assessment of poly(ADP-ribose)polymerase-1 role in normal and cancer cells [J]. Biofactors, 2020, 46(6): 894-905.
[1] 张舒淇,江延姣,印丹. 生殖道微生物与子宫内膜异位症发展之间的联系[J]. 山东大学学报 (医学版), 2025, 63(5): 120-126.
[2] 徐萍,张信美. 子宫内膜异位症疼痛的机制[J]. 山东大学学报 (医学版), 2025, 63(10): 1-7.
[3] 黄艳,周应芳,彭超. 青少年子宫内膜异位症的管理要点和策略[J]. 山东大学学报 (医学版), 2025, 63(10): 8-12.
[4] 薛铭,梁静,凌斌. 各种类型子宫内膜异位症疼痛特点及治疗研究进展[J]. 山东大学学报 (医学版), 2025, 63(10): 13-19.
[5] 赵书睿,赵烨. 围绝经期及绝经后期子宫内膜异位症的诊疗现状[J]. 山东大学学报 (医学版), 2025, 63(10): 20-26.
[6] 梁炎春,严莹,麦华希,姚书忠. 地诺孕素在子宫内膜异位症相关性疼痛中的治疗作用:从基础到临床[J]. 山东大学学报 (医学版), 2025, 63(10): 27-33.
[7] 董向毅,刘昕,刘欣欣,徐亚瑄,赵琳丽,陶国伟. 盆腔深部子宫内膜异位症的超声评价[J]. 山东大学学报 (医学版), 2025, 63(10): 34-42.
[8] 刘振花,连雅囡,米国琳. 子宫内膜异位症疼痛的心理因素及干预措施的研究进展[J]. 山东大学学报 (医学版), 2025, 63(10): 43-51.
[9] 杜煜晗,孙莹,杜惠兰. 红花如意丸对寒凝血瘀型子宫内膜异位症痛经患者疼痛的疗效及机制[J]. 山东大学学报 (医学版), 2025, 63(10): 52-60.
[10] 金珊,高杰,谢玉姣,展垚,杜甜甜,王传新. 甲基转移酶PRMT5稳定USP15促进乳腺癌发生发展的作用[J]. 山东大学学报 (医学版), 2023, 61(7): 1-11.
[11] 张丽霞,田一正,吕尚格,张亚男,颜磊. GnRH-a预处理对子宫内膜异位症患者替代方案冻胚移植结局的影响[J]. 山东大学学报 (医学版), 2023, 61(10): 63-68.
[12] 颜磊,岳彩欣,刘懿淳. 子宫内膜异位症的生育力保护[J]. 山东大学学报 (医学版), 2022, 60(9): 31-34.
[13] 冷金花, 史精华. 子宫腺肌病的临床表现[J]. 山东大学学报 (医学版), 2022, 60(7): 1-5.
[14] 陈忠绍,褚然,李明宝,张向宁. MRKH综合征相关腹股沟子宫疝修补术后腹壁瘢痕子宫内膜异位症1例报道并文献复习[J]. 山东大学学报 (医学版), 2022, 60(5): 114-117.
[15] 单婧,王晓秋,李大金. NK细胞参与子宫内膜异位症及其不孕的分子机制[J]. 山东大学学报 (医学版), 2021, 59(8): 8-13.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
版权所有 © 2018 《山东大学学报(医学版)》编辑部　
地址:山东大学科技期刊社（济南市历城区山大南路27号山东大学中心校区明德楼B座721室） 电话: 0531-88366918 E-mail: xbyxb@sdu.edu.cn
本系统由北京玛格泰克科技发展有限公司设计开发